Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0001112
UniProt IDP35637
Primary gene name(s)FUS
Synonym gene name(s)TLS
Protein nameRNA-binding protein FUS
Protein functionBinds both single-stranded and double-stranded DNA and promotes ATP-independent annealing of complementary single-stranded DNAs and D-loop formation in superhelical double-stranded DNA. May play a role in maintenance of genomic integrity.
Subcellular locationNucleus {ECO:0000269|PubMed:19251627, ECO:0000269|PubMed:19251628}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P35637
Gene Ontology
(Biological Process)
Complete annatation
cellular response to calcium ion [GO:0071277];
mRNA splicing, via spliceosome [GO:0000398]
Gene Ontology
(Molecular Function)
Complete annatation
DNA binding [GO:0003677];
identical protein binding [GO:0042802];
nucleotide binding [GO:0000166];
poly(A RNA binding [GO:0044822];
RNA binding [GO:0003723];
transcription coactivator activity [GO:0003713];
zinc ion binding [GO:0008270]
Gene Ontology
(Cellular Component)
Complete annatation
dendritic spine head [GO:0044327];
nucleoplasm [GO:0005654];
nucleus [GO:0005634];
perikaryon [GO:0043204];
perinuclear region of cytoplasm [GO:0048471];
polysome [GO:0005844]
Protein-protein interaction108797
Phylogenetic treeP35637
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD31.273597405971660.0001260507526040790.000593328214631067
AZA vs. DISU-0.4632008876649430.06849841718518010.571825243103445
AZA vs. IL70.3801754207625190.04758346558165180.644768550316037
AZA vs. SAHA0.1009311703117660.6783486208050980.90621672242426
DISU vs. CD3-1.750010993190292.65669138133084e-062.29101635481586e-05
DISU vs. IL70.8337703807456150.001019422689631290.0276399227449491
DISU vs. SAHA0.5663940143687840.05300249554262160.288688330438327
DMSO vs. AZA0.1237380223130350.4582711623270881
DMSO vs. CD3-1.156685984223930.0003498383887200470.00136148678017761
DMSO vs. DISU0.5865364055826940.01688629799035270.269620219713406
DMSO vs. IL70.2630018130299040.1424309143949330.644401570979478
DMSO vs. SAHA-0.03014348653921140.8980034287054070.975026503245809
HIV vs. Mock in Activation0.3181319692554720.6091564753596410.999983755607037
HIV vs. Mock in Latency-0.04500513385915470.7844365744729880.999834320637052
IL7 vs. CD3-0.8877186534561150.006004031225999910.019566563433683
SAHA vs. CD3-1.196379218633040.0008188491700339420.00301241232720004
SAHA vs. IL7-0.2816606390543120.2465014135149980.488594649220918
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change -1.151885742
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.455466 0.0480895
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.034 0.978 0.888 0.861 1.027
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
2LA6 NMR - A=282-370.
2LCW NMR - A=278-385.
4FDD X-ray 2.3Å B=498-526.
4FQ3 X-ray 3.0Å B=495-526.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Rev interacts with 22174317
Tat interacts with 25496916

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa05202 Transcriptional misregulation in cancer - Homo sapiens (human)